Impact of palliative care on medication use and medical utilization in patients with advanced cancer.
- Author:
Dingyi CHEN
1
;
Haoxin DU
1
;
Yichen ZHANG
1
;
Yanfei WANG
2
;
Wei LIU
2
;
Yuanyuan JIAO
2
;
Luwen SHI
1
;
Xiaodong GUAN
1
;
Xinpu LU
2
Author Information
1. Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical sciences, Beijing 100191, China.
2. Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing 100142, China.
- Publication Type:Journal Article
- Keywords:
Drug utilization;
Medical expenditure;
Medical service utilization;
Neoplasm;
Opium;
Palliative care
- MeSH:
Humans;
Palliative Care/economics*;
Neoplasms/drug therapy*;
Analgesics, Opioid/economics*;
Male;
Female;
Middle Aged;
Aged;
Hospitalization/economics*;
Intensive Care Units/statistics & numerical data*;
Health Expenditures/statistics & numerical data*;
Adult;
Drug Utilization/statistics & numerical data*;
Patient Acceptance of Health Care/statistics & numerical data*
- From:
Journal of Peking University(Health Sciences)
2025;57(5):996-1001
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the effect of palliative care on drug use, medical service utilization and medical expenditure of patients with advanced cancer.
METHODS:A cohort of patients including pal-liative care and standard care was constructed using the medical records of the patients in Peking University Cancer Hospital from 2018 to 2020, and coarsened exact matching was used to match the two groups of patients. The average monthly opioid consumption, hospitalization rate, intensive care unit (ICU) rate and operation rate, and the average monthly total cost were selected to evaluate drug use, medical service utilization and medical expenditure. Chi-square test and Wilcoxon signed rank test were used to compare the differences between the two groups before and after exposure and the change in the palliative care group. The net impact of palliative care on the patients was calculated using the difference-in-differences analysis.
RESULTS:In this study, 180 patients in the palliative care group and 3 101 patients in the stan-dard care group were finally included in the matching, and the matching effect of the two groups was good (L1 < 0.1). Before and after exposure, the average monthly opioid consumption in the palliative care group was significantly higher than that in the standard care group (Before exposure: 0.3 DDD/person-month vs. 0.1 DDD/person-month, P < 0.01; After exposure: 0.7 DDD/person-month vs. 0.1 DDD/person-month, P < 0.01; DDD refers to defined daily dose), palliative care significantly increased the average monthly opioid consumption in the patients (0.3 DDD/person-month, P < 0.01). The hospitalization rate (48.9% vs. 74.3%, P < 0.01) and operation rate (3.9% vs. 8.8%, P < 0.01) of the patients in palliative care group were significantly lower than those in standard care group, and the ICU rate became similar between the two groups (1.1% vs. 1.6%, P=0.634). Palliative care significantly reduced the patients ' hospitalization rate (-25.6%, P < 0.01), ICU rate (-4.9%, P < 0.01) and operation rate (-14.5%, P < 0.01). Before and after exposure, the average monthly total costs of pal-liative care group were slightly higher than those of standard care group (Before exposure: 20 092.3 yuan vs. 19 132.8 yuan, P=0.725; After exposure: 9 719.8 yuan vs. 8 818.8 yuan, P=0.165). Palliative care increased the average monthly total cost by 2 208.8 yuan, but it was not statistically significant (P=0.316).
CONCLUSION:Palliative care can increase the opioid consumption in advanced cancer patients, reduce the rates of hospitalization, ICU and surgery, but has no significant effect on medical expenditure.
